Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simethicone and N-acetylcysteine in Upper Endoscopy
NCT02357303Phase 4Completed
- Sponsor
- IPO Coimbra
- Start
- Apr 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing Placebo, Simethicone and Simethicone + NAC (3 arms). Primary endpoint: Score of mucosal visualization at 1 day. Started Apr 2015; status: completed.
02
Drugs
simethiconeacetylcysteine
Beyond the preview
Go deeper on NCT02357303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357303.